MASS SPECTROMETRY REVIEWS质谱学评论
MASS SPECTROMETRY REVIEWS(英文缩写 MASS SPECTROM REV),ISSN 0277-7037,eISSN 1098-2787,中文译名:质谱学评论 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-09-28 至 2026-09-28，按本站收录文献的发表日期统计。
期刊介绍
历年影响因子趋势
| JCR 数据年份 | 影响因子 | JCR 分区 |
|---|---|---|
| 2021 | 9.011 | Q1 |
| 2022 | 6.600 | Q1 |
| 2023 | 6.900 | Q1 |
| 2024 | 6.600 | Q1 |
| 2025 | 6.000 | Q1 |
MASS SPECTROMETRY REVIEWS 最新收录文献
-
1. Analysis of Carbohydrates and Glycoconjugates by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry: An Update for 2023-2024.
PMID:日期:2026-09-24The use of MALDI mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well-established technique and this comprehensive review is the twelfth update of the original article published in 1999 and brings coverage of the literature to the end of 2024. Although still popular for glycoconjugate analysis, recent years have seen a slight drop in its usage with electrospray and LC-MS techniques becoming more widely used. The review follows the same general format as previous reviews. Much of the material relating to applications is presented in tabular form whereas papers relating to method development are discussed in more detail. The review is divided into three sections: (1) general aspects such as theory of the MALDI process, matrices, derivatization, MALDI imaging, fragmentation, quantification, and the use of computer software for structural identification. (2) Applications to various structural types such as oligo- and polysaccharides, glycoproteins, glycated proteins, glycolipids and natural products, and (3) other general areas such as medicine, biopharmaceuticals, industrial processes and glycan synthesis where MALDI is extensively used. As with previous reviews in this series, this review also includes a few papers that describe methods appropriate to analysis by MALDI, such as sample preparation, even though the ionization method is not MALDI. Much of this work is tabulated. MALDI is still an ideal technique for carbohydrate analysis, particularly in its rapidity, ease of use and its ability to produce single ions from each analyte. Improvements in the technique and range of applications show little sign of diminishing.
-
3. Mass Spectrometry in Authentication and Forensic Approaches for Determining the Origin of Hazardous Chemicals.
PMID:日期:2026-09-07Identification of a chemical agent yields insights into its physicochemical properties. By examining the intrinsic characteristics and environment of a compound, information about its history can be gathered. The main objective of authentication/forensic approaches to chemicals is to trace the history of the compound's origin, regardless of its nature (e.g., environmental pollutants, drugs, or toxicants). This review presents several scientific fields that share a common objective: using mass spectrometry (MS) to obtain source information from diverse samples and chemicals. From targeted analysis to the full screening of non-targeted chemical space, direct and coupled MS approaches provide powerful capabilities for addressing source-determination concerns, as described in this review. Novel sampling and ionization methods have proven to have a significant impact on expanding MS applications across diverse sample types. This review covers the main methods for determining chemical origins, ranging from targeted confirmation of known compounds to non-targeted identification of unknown compounds under challenging experimental and matrix-related conditions.
-
4. Advances in Mass Spectrometry-Based Proteomics for Kidney Disease Biomarker Discovery and Clinical Translation.
PMID:日期:2026-08-22The high prevalence and substantial burden of kidney diseases necessitate advanced approaches to elucidate molecular mechanisms and promote precision medicine. Mass spectrometry (MS)-based proteomics has evolved into a widely used analytical platform, delivering high-sensitivity, high-throughput protein profiling capabilities that have contributed substantially to biomarker discovery, mechanistic dissection, and therapeutic target identification across a broad range of kidney diseases. This review provides a comprehensive overview of MS-based proteomics applications in kidney disease research, covering progress in biomarker identification, pathogenic mechanism interrogation, and clinical translation. It highlights methodological advances, emerging trends, and persistent challenges that shape the field. Existing literature has uncovered abundant disease-specific biomarkers and revealed key pathogenic pathways, including podocyte injury-associated protein interaction networks, dysregulated complement activation, and metabolic reprogramming, and have critically assessed their translational potential. Additionally, investigations into posttranslational modifications such as phosphorylation and glycosylation have provided valuable insights for targeted therapies. Collectively, these findings illustrate the contributions of MS-based proteomics to the characterization of disease molecular heterogeneity, the identification of key pathogenic drivers, and the development of precision medicine approaches. This review further addresses current challenges in clinical applications, including sample heterogeneity, data complexity, and standardization issues. We additionally emphasize the critical need for minimum reporting standards and multicenter harmonization to accelerate the clinical translation of renal proteomics. Future research should focus on integrating multiomics and artificial intelligence-driven data mining to enhance precise disease subtyping, dynamic monitoring, and personalized treatment strategies.
-
5. Mass Spectrometry-Based Extracellular Vesicle Proteomics for Biomarker Discovery.
PMID:日期:2026-08-03Extracellular vesicle (EV) proteomics has emerged as a powerful platform for decoding intercellular communication and advancing biomarker discovery across human diseases. EVs carry proteins that reflect their cells of origin, offering a minimally invasive window into physiological and pathological processes. Mass spectrometry (MS) now enables deep, high-resolution EV proteome profiling, aided by improved isolation and rigorous characterization that ensure sample purity and integrity. Advanced computational pipelines integrating quantitative modeling, spectral-library prediction, machine learning and multi-omics analysis extract meaningful biological signals, revealing subtle disease-associated EV signatures and establishing EV proteomics as a strong platform for biomarker discovery and precision medicine. This review provides an integrated framework linking EV isolation principles, characterization strategies, mass-spectrometric workflows, and computational analysis to the biological and clinical insights they generate. We also highlight key challenges and future directions, including the need for standardized reference materials, unified pre-analytical workflows, and EV proteome reference atlases. Together, these innovations are transforming EV proteomics into a next-generation tool for precision medicine.
-
6. The Rise of Top-Down Mass Spectrometry for the Characterization of Oligonucleotide Therapeutics.
PMID:日期:2026-07-09The therapeutic landscape has been rapidly expanding beyond traditional small molecules and biologics in recent years with the emergence of oligonucleotide therapeutics. As these oligonucleotide modalities grow in complexity and chemical modifications, conventional digestion-based mass spectrometry strategies start to yield redundant and ambiguous information. Alternatively, the top-down approach has the potential to provide a holistic view of therapeutic oligonucleotides. This review examines the rise of top-down mass spectrometry for the characterization of therapeutic oligonucleotides, with a focus on technological and methodological advances between 2020 and 2025. We cover sample preparation, sample introduction including separation, ionization, mass analysis, fragmentation approaches, data analysis strategies, and a discussion of long oligonucleotide and beyond for oligonucleotide top-down analysis. Finally, we provide a practical top-down workflow guidance on therapeutic oligonucleotides and conclude with a forward-looking perspective on the frontiers of the field.
-
7. Comprehensive Tutorial for Computational Methods of Protein Structure Prediction Incorporating Mass Spectrometry Data.
PMID:日期:2026-07-07Here we present a series of tutorials demonstrating the use of various methods which integrate structural mass spectrometry (MS) data with computational protein structure prediction methods. We give usage examples of widely used modeling frameworks, including Rosetta-based approaches (ab initio modeling, comparative modeling, and protein-protein docking) and deep learning methods such as AlphaFold2. We then describe strategies for incorporating covalent labeling, ion mobility, and surface-induced dissociation MS data into these workflows through Rosetta scoring terms and specialized applications. Finally, we provide instructions on calculating structural metrics, such as solvent accessibility, collision cross sections, and energy-resolved MS data and comparing them to actual MS data. We also introduce new PyRosetta implementations of the PARCS algorithm and the SID_ERMS_Rescore application. Together, these tutorials provide a comprehensive framework for integrating computational modeling with structural MS to enhance protein structure prediction.
-
8. Mass Spectrometry Insights Into Post-Translational Modifications in Extracellular Vesicles.
PMID:日期:2026-06-28Extracellular vesicles (EVs) are membrane-enclosed structures secreted by virtually all living cells, serving as essential mediators of intercellular communication in both physiological and pathological processes. There is growing interest in their potential applications as biomarkers, therapeutic targets, and drug delivery systems, which entails the need for a detailed understanding of their molecular composition. The functional cargo of EVs includes all types of biological macromolecules, among which proteins are of particular importance. As the vesicular proteome becomes increasingly mapped, research attention is gradually shifting toward post-translational modifications (PTMs), which fundamentally influence protein function and play key roles in all aspects of vesicular activity, including biogenesis, cargo sorting, recognition, and uptake. In this review, we outline recent advances in the application of mass spectrometry (MS)-based analysis of PTMs in EVs. In this context, we provide an overview of the roles of various PTMs in EV biology, discuss the impact of EV isolation methods on downstream PTM analyses, and address current challenges and approaches related to MS-based investigations. We further highlight key findings concerning specific PTMs, including glycosylation, phosphorylation, acetylation, methylation, lipidation, and small ubiquitin-like modifier (SUMOylation). Finally, we discuss studies focusing on the simultaneous analysis of multiple PTMs, as well as efforts toward multiomic data integration and single-EV characterization to resolve vesicular heterogeneity, highlighting these approaches as cutting-edge directions in the field.
-
9. Standardization Challenges and Breakthroughs in Apolipoprotein B Detection: From Immunoassays to LC-MS/MS.
PMID:日期:2026-06-24Apolipoprotein B (apoB) is a key biomarker for risk assessment and treatment monitoring of atherosclerotic cardiovascular disease (ASCVD). Its clinical value has been validated by multiple studies, and its predictive performance for ASCVD risk is significantly superior to conventional lipid indicators in populations with complex lipid profiles. However, the standardization of apoB detection has long been a core bottleneck restricting its widespread clinical application, as discrepancies in results between different methods and laboratories can biases in clinical decision-making. In recent years, the development of Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) technology has provided a solution for optimizing apoB standardization. Currently, International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) is promoting the development of a primary reference measurement procedure based on mass spectrometry, aiming to achieve apoB standardization traceable to the International System of Units (SI). This review systematically outlines the clinical value of apoB, main detection methods, standardization challenges, and the application and prospects of LC-MS/MS in overcoming these challenges. We aim to provide insights for further optimizing apoB detection standardization.
-
10. The Rise of Trapped Ion Mobility Spectrometry: Principles, Applications, and Recent Developments.
PMID:日期:2026-06-16Trapped ion mobility spectrometry (TIMS) is a highly versatile alternative to the more conventional drift tube ion mobility spectrometer (DTIMS). In TIMS, ions are analyzed using an electric field that holds ions stationary against moving gas. In the basic TIMS, ions are accumulated and trapped in the electric field and then eluted over time according to their collision cross section (CCS) as the strength of the electric field is scanned down. The resultant small size and low operating voltage of TIMS compared to prior approaches make it ideal for hybridization with mass spectrometry. Since its introduction and coupling with Time-of-Flight Mass Spectrometry (TOFMS) in 2011, TIMS has been widely and successfully applied in various bioanalytical fields, including proteomics, glycomics, metabolomics, lipidomics, and native mass spectrometry. In particular, the first commercial TIMS-MS instrument introduced by Bruker Daltonics Inc. (timsTOF), launched in 2016, quickly shined as one of the main reference instruments in bottom-up proteomics. The increased peak capacity, resulting from the additional dimension of separation-that is, mobility-leads to mass spectra of reduced complexity and a greater depth of peptide identification. In this retrospective, different designs and operational modes of TIMS will be presented with a focus on the advantages, potentials and challenges of this technology within the fields of the omics sciences, spanning from metabolomics to structural biology, including single cell analysis. Additionally, the newest platforms utilizing TIMS technology will be introduced, with a focus on future applications and direction of the technology.